AnodyneWiki

Harmine

Harmine
Harmine
Salts
[]
Harmine hydrochloride
Harmine hydrochloride
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass212.25 g/mol [1]
Melting point264 - 265 °C [1]
Predicted LogP3.6 [1]
Structural Identifiers
[]
Molecular formulaC13H12N2O
IUPAC name7-methoxy-1-methyl-9H-pyrido[3,4-b]indole
SMILESCC1=NC=CC2=C1NC3=C2C=CC(=C3)OC
InChIInChI=1S/C13H12N2O/c1-8-13-11(5-6-14-8)10-4-3-9(16-2)7-12(10)15-13/h3-7,15H,1-2H3
InChIKeyBXNJHAXVSOCGBA-UHFFFAOYSA-N
CAS number442-51-3
UNII4FHH5G48T7
PubChem CID5280953
Pharmacokinetics[]
OnsetUnknown
Elimination half-life1.3–1.9 hours (1–3 hours)[3]
Duration of actionOral: 6–8 hours, Intramuscular injection: 3–5 hours, Intravenous injection: 30–45 minutes[4][5][6]
Routes of administrationOral, sublingual, subcutaneous injection, intramuscular injection, intravenous injection

Harmine (also known as Banisterine, Telepathine, Leucoharmine, Yageine, Yajeine, 9H-Pyrido[3,4-b]indole, 7-methoxy-1-methyl-, 1-Methyl-7-methoxy-β-carboline, 7-Methoxy-1-methyl-9H-pyrido(3,4-b)indole, 9H-Pyrido(3,4-b)indole, 7-methoxy-1-methyl- or 207-131-4) is a monoamine oxidase inhibitor substance of the β-carboline class.

It is a constituent of tobacco.

Chemistry

Salts []

Harmine is typically found in the form of its hydrochloride salt.

 []

Harmine is achiral.

Harmine matches Lipinski's rule of five.

There are currently 6 reagent-interactions on

ReagentColor changeDescription
Marquisyellow > red
Meckeyellow > green
Mandelinblack
Simon'sno blue color change
Ehrlichno color change
Hofmannno color change

Pharmacology

Experience reports

Erowid

There are currently 7 experience reports involving harmine on : []

Reddit

There are currently 2 trip reports involving harmine on : []

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 5280953, Harmine. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/5280953
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Harmine. UNII: 4FHH5G48T7. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/4FHH5G48T7
  3. Brito-da-Costa AM, Dias-da-Silva D, Gomes NG, Dinis-Oliveira RJ, Madureira-Carvalho Á. Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids N,N-Dimethyltryptamine (DMT), Harmine, Harmaline and Tetrahydroharmine: Clinical and Forensic Impact. Pharmaceuticals (Basel). October 2020; 13(11):334. PMID 33114119.
  4. Dos Santos RG, Hallak JE. Ayahuasca: pharmacology, safety, and therapeutic effects. CNS Spectr. November 2024; 30(1). PMID 39564645.
  5. Mueller MJ, Aicher HD, Dornbierer DA, Marten L, Suay D, Meling D, Elsner C, Wicki IA, Müller J, Poetzsch SN, Caflisch L, Hempe A, Steinhart CP, Puchkov M, Kost J, Landolt HP, Seifritz E, Quednow BB, Scheidegger M. Pharmacokinetics and pharmacodynamics of an innovative psychedelic N,N-dimethyltryptamine/harmine formulation in healthy participants: a randomized controlled trial. Int J Neuropsychopharmacol. December 2024; 28(1). PMID 39774840.
  6. Egger K, Jareño Redondo J, Müller J, Dornbierer J, Smallridge J, Aicher HD, Meling D, Müller P, Kost J, Puchkov M, Äbelö A, Seifritz E, Quednow BB, von Rotz R, Scheidegger M, Dornbierer DA. Examining the pharmacokinetic and pharmacodynamic interaction of N,N-dimethyltryptamine and harmine in healthy volunteers: Α factorial dose-escalation study. Biomed Pharmacother. March 2025; 184(). PMID 39923404.

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 11:54:57
drugsprook2026-11-20 11:54:53
erowidok2026-11-20 11:54:58
gsrsok2026-11-20 11:54:54
hmdbmissing (hmdb.ca refused automated access to HMDB0030311)2026-11-20 11:54:53
keggmissing (no KEGG DRUG entry)2026-11-20 11:54:57
pubchemok2026-11-20 11:54:53
redditok2026-11-20 11:54:53
sidermissing (not in SIDER)2026-11-20 11:54:53
structureok2026-11-20 11:54:53
wikipediaok2026-11-20 11:54:54